The SLE associate TT>A risk alleles, through their inability to effectively deliver NF-κB to the TNFAIP3 promoter, impair A20 expression leading to enhanced NF-κB pathway activity and predisposition to autoimmune disease. The gene discussed is NFKB1; the disease is systemic lupus erythematosus.